Abstract:BACKGROUND: Retinoid X receptor-alpha (RXRα) is a key member of the nuclear receptor superfamily. We recently demonstrated that proteolytic cleavage of RXRα resulted in production of a truncated product, tRXRα, which promotes cancer cell survival by activating phosphatidylinositol-3-OH kinase (PI3K)/AKT pathway. However, how the tRXRα-mediated signaling pathway in cancer cells is regulated remains elusive. METHODOLOGY/PRINCIPAL FINDINGS: We screened a natural product library for tRXRα targeting leads and identified that triptolide, an active component isolated from traditional Chinese herb Trypterygium wilfordii Hook F, could modulate tRXRα-mediated cancer cell survival pathway in vitro and in animals. Our results reveal that triptolide strongly induces cancer cell apoptosis dependent on intracellular tRXRα expression levels, demonstrating that tRXRα serves as an important intracellular target of triptolide. We show that triptolide selectively induces tRXRα degradation and inhibits tRXRα-dependent AKT activity without affecting the full-length RXRα. Interestingly, such effects of triptolide are due to its activation of p38. Although triptolide also activates Erk1/2 and MAPK pathways, the effects of triptolide on tRXRα degradation and AKT activity are only reversed by p38 siRNA and p38 inhibitor. In addition, the p38 inhibitor potently inhibits tRXRα interaction with p85α leading to AKT inactivation. Our results demonstrate an interesting novel signaling interplay between p38 and AKT through tRXRα mediation. We finally show that targeting tRXRα by triptolide strongly activates TNFα death signaling and enhances the anticancer activity of other chemotherapies. CONCLUSIONS/SIGNIFICANCE: Our results identify triptolide as a new xenobiotic regulator of the tRXRα-dependent survival pathway and provide new insight into the mechanism by which triptolide acts to induce apoptosis of cancer cells. Triptolide represents one of the most promising therapeutic leads of natural products of traditional Chinese medicine with unfortunate side-effects. Our findings will offer new strategies to develop improved triptolide analogs for cancer therapy.

Triptolide induces apoptosis and cytoprotective autophagy by ROS accumulation via directly targeting peroxiredoxin 2 in gastric cancer cells

Triptolide Induces Apoptosis of Gastric Cancer Cells Via Inhibiting the Overexpression of MDM2.

Antagonist Effect of Triptolide on Akt Activation by Truncated Retinoid X Receptor-Alpha

Triptolide Induces Apoptosis and Autophagy in Cutaneous Squamous Cell Carcinoma <i>via</i> Akt/mTOR Pathway

Data from Natural Product Triptolide Mediates Cancer Cell Death by Triggering CDK7-Dependent Degradation of RNA Polymerase II

Increased Accumulation of Hypoxia-Inducible Factor-1Α with Reduced Transcriptional Activity Mediates the Antitumor Effect of Triptolide.

Triptolide Induces Apoptosis of Human Pancreatic Cancer Cells

Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the death receptor pathway

Triptolide induces apoptosis of glioma cells by inhibiting NF-κB activation during oxidative stress

Involvement of Mitochondrial Pathway in Triptolide-Induced Cytotoxicity in Human Normal Liver L-02 Cells

Ginsenoside Rb1 Attenuates Triptolide-Induced Cytotoxicity in HL-7702 Cells via the Activation of Keap1/Nrf2/ARE Pathway

Peroxiredoxin V Silencing Elevates Susceptibility to Doxorubicin-induced Cell Apoptosis via ROS-dependent Mitochondrial Dysfunction in AGS Gastric Cancer Cells

Triptolide induces autophagy and apoptosis through ERK activation in human breast cancer MCF-7 cells

Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells

Triptolide Induces Growth Inhibition And Apoptosis Of Human Laryngocarcinoma Cells By Enhancing P53 Activities And Suppressing E6-Mediated P53 Degradation

Triptolide Induces S Phase Arrest and Apoptosis in Gallbladder Cancer Cells

Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ

Triptolide induces apoptosis through the calcium/calmodulin‑dependent protein kinase kinaseβ/AMP‑activated protein kinase signaling pathway in non‑small cell lung cancer cells.

Autophagy Plays an Important Role in Triptolide-Induced Apoptosis in Cardiomyocytes.

Broad targeting of triptolide to resistance and sensitization for cancer therapy

Triptolide Induces Mitochondrial Apoptosis Through Modulating Dual Specificity Phosphatase 1/Mitogen-Activated Protein Kinases Cascade in Osteosarcoma Cells